The Atlantis Translational® Anterior Cervical Plate System is a ratcheting plate featuring segments that translate under compression, but maintain their position under tension. Test results demonstrated that the unidirectional plate had less motion in flexion-extension and maintained a more consistent graft load when compared to bidirectional design.1,2 These comparative study test results are based on non-clinical testing. Clinical outcomes may vary.
This system is intended for use in temporary stabilization of the anterior cervical spine (C2-T1) during the development of spinal fusions in patients with: (1) degenerative disc disease, (2) trauma, (3) tumors, (4) deformity, (5) pseudoarthrosis, and/or (6) failed previous fusions.
Benefits:
- Unidirectional Translation
- Allows axial load-sharing between the graft and the vertebral body end plate.1
- Allows unidirectional translation up to 2 mm per level in 1mm increments.
- Unidirectional movement provides a continuous compressive load between the end plate and the bone graft based on nonclinical testing.1,2 Not indicative of human clinical outcomes.
- Allows intraoperative precompression.
- Adjustable plate allows flexibility of screw placement on vertebral body to fit pathology and patient anatomy (e.g., corpectomy, larger patients).
- Unidirectional mechanism allows the plate to function as a static plate when in the fully collapsed position.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.